Malamas; Michael S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Malamas; Michael S..The latest application filed is for "n-acylethanolamine hydrolyzing acid amidase (naaa) inhibitors and use thereof".

Company Profile

2.32.24

Malamas; Michael S. - Jamison PA
Malamas; Michael S - Jamison PA
Malamas; Michael S. - Plainsboro NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof Grant 10,689,357 - Malamas , et al.	2020-06-23
N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Use Thereof App 20190345132 - Malamas; Michael S. ; et al.	2019-11-14
Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders Grant 7,875,618 - Malamas , et al. January 25, 2	2011-01-25
Imidazo[5,1-c][1,2,4]benzotriazine Derivatives As Inhibitors Of Phosphodiesterases App 20100120763 - Stange; Hans ; et al.	2010-05-13
Triazine derivatives as inhibitors of phosphodiesterases App 20100120762 - Stange; Hans ; et al.	2010-05-13
Amino-5,5-diphenylimidazolone derivatives for the inhibition of .beta.-secretase Grant 7,700,602 - Malamas , et al. April 20, 2	2010-04-20
ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF PHOSPHODIESTERASE 10 App 20090143367 - Malamas; Michael S. ; et al.	2009-06-04
Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 App 20090143361 - Malamas; Michael S. ; et al.	2009-06-04
Substituted benzoxazoles as estrogenic agents Grant 7,531,564 - Malamas , et al. May 12, 2	2009-05-12
Amino-5,5-diphenylimidazolone Derivatives For The Inhibition Of Beta-secretase App 20090093498 - Malamas; Michael S. ; et al.	2009-04-09
DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE App 20090042912 - Malamas; Michael S. ; et al.	2009-02-12
Amino-5,5-diphenylimidazolone derivatives for the inhibition of .beta.-secretase Grant 7,482,349 - Malamas , et al. January 27, 2	2009-01-27
Diphenylimidazopyrimidines as inhibitors of .beta.-secretase Grant 7,456,186 - Malamas , et al. November 25, 2	2008-11-25
Substituted benzoxazoles as estrogenic agents App 20070167503 - Malamas; Michael S. ; et al.	2007-07-19
Substituted benzoxazoles as estrogenic agents Grant 7,148,247 - Malamas , et al. December 12, 2	2006-12-12
Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia Grant 7,141,672 - Malamas November 28, 2	2006-11-28
Substituted benzoxazoles as estrogenic agents Grant 7,129,258 - Malamas , et al. October 31, 2	2006-10-31
Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase App 20050282826 - Malamas, Michael S. ; et al.	2005-12-22
Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase App 20050282825 - Malamas, Michael S. ; et al.	2005-12-22
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents App 20050272786 - Malamas, Michael S. ; et al.	2005-12-08
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents Grant 6,960,607 - Malamas , et al. November 1, 2	2005-11-01
Substituted benzoxazoles as estrogenic agents App 20050239851 - Malamas, Michael S. ; et al.	2005-10-27
Phenyl benzisoxazoles as estrogenic agents App 20050159465 - Malamas, Michael S. ; et al.	2005-07-21
Phenyl benzisoxazoles as estrogenic agents Grant 6,884,814 - Malamas , et al. April 26, 2	2005-04-26
Substituted benzoxazoles as estrogenic agents App 20050080117 - Malamas, Michael S. ; et al.	2005-04-14
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,844,358 - Malamas , et al. January 18, 2	2005-01-18
Substituted benzoxazoles as estrogenic agents Grant 6,794,403 - Malamas , et al. September 21, 2	2004-09-21
Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia App 20040147755 - Malamas, Michael S.	2004-07-29
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia App 20040102480 - Malamas, Michael S. ; et al.	2004-05-27
Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,699,896 - Malamas March 2, 2	2004-03-02
Phenyl benzisoxazoles as estrogenic agents App 20030207927 - Malamas, Michael S. ; et al.	2003-11-06
Substituted benzoxazoles as estrogenic agents App 20030199562 - Malamas, Michael S. ; et al.	2003-10-23
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents App 20030171412 - Malamas, Michael S. ; et al.	2003-09-11
Azolidines as beta-3 adrenergic receptor agonists App 20020032222 - Malamas, Michael S. ; et al.	2002-03-14
Cyclic amine phenyl beta-3 adrenergic receptor agonists App 20020028835 - Hu, Baihua ; et al.	2002-03-07
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists App 20020028797 - Sum, Fuk-Wah ; et al.	2002-03-07
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia App 20010053785 - Malamas, Michael S. ; et al.	2001-12-20
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia App 20010041715 - Malamas, Michael S. ; et al.	2001-11-15
Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,310,081 - Malamas , et al. October 30, 2	2001-10-30
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia Grant 6,214,842 - Malamas , et al. April 10, 2	2001-04-10
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,166,069 - Malamas , et al. December 26, 2	2000-12-26
Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,110,963 - Malamas August 29, 2	2000-08-29
Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents Grant 5,677,342 - Malamas , et al. October 14, 1	1997-10-14
Aryl-n-hydroxyureas as inhbitors of 5-lipoxygenase and anti-arteriosclerotic agents Grant 5,541,205 - Malamas , et al. July 30, 1	1996-07-30
New azolidinediones and thiadiazolidinediones as antihyperglycemic agents Grant 5,532,256 - Malamas , et al. July 2, 1	1996-07-02
N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein Grant 5,504,097 - Malamas , et al. April 2, 1	1996-04-02
2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-oxazoles as anti-atherosclerotic agents Grant 5,491,159 - Malamas February 13, 1	1996-02-13
Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents Grant 5,480,896 - Malamas , et al. January 2, 1	1996-01-02
Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein Grant 5,468,760 - Malamas , et al. November 21, 1	1995-11-21
Azolidinediones as antihyperglycemic agents Grant 5,468,762 - Malamas , et al. November 21, 1	1995-11-21
Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents Grant 5,428,048 - Malamas , et al. June 27, 1	1995-06-27
1'-am ino-2[(benzothiazolyl)methyl]spiro-[isoquinoline-4(1H),3'-pyrrolidine]-1, 2'3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors Grant 5,189,168 - Malamas * February 23, 1	1993-02-23
Spiro-lactams and analogs thereof useful as aldose reductase inhibitors Grant 5,130,425 - Malamas July 14, 1	1992-07-14
Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors Grant 5,037,831 - Malamas August 6, 1	1991-08-06
N-[[6 -methoxy-5-(trifluoromethyl)-1-naphthalenyl]-thioxomethyl]-N-methylglycin e S-oxide and the amide thereof Grant 4,994,381 - Ferdinandi , et al. February 19, 1	1991-02-19
N-[[6-methoxy-5-(trifluoromethyl)-1-naphthalenyl]-thioxome thyl]-N-methylglycine S-oxide and the amide thereof Grant 4,734,435 - Ferdinandi , et al. March 29, 1	1988-03-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.